A new study published recently in New England Journal of Medicine (NEJM) by Dr. Peter Schmid of Barts Cancer Institute, Queen Mary University of London, and his colleagues, has found that combining immunotherapy with chemotherapy could improve the outcome for some advanced triple negative breast cancer patients
Internet is huge! Help us find great content
Never miss a thing! Sign up for our newsletter to stay updated.
Research Stash is a curated collection of tools and News for S.T.E.M researchers
Have any questions or want to partner with us? Reach us at hello@researchstash.com
